NEW YORK: Pfizer has appointed Burson-Marsteller to handle US and international strategy for Pregabalin, a treatment for neuropathic pain and adjunctive therapy in epilepsy, which is currently pending review in the US and in Europe.
According to Ame Wadler, chairman of Burson's US healthcare practice, Edelman was the other agency invited by Pfizer to pitch for the US and international business. Hill & Knowlton was asked to pitch for just the international portion of the account, while GCI and Chandler Chicco ...